The ubiquitin-proteasome pathway and serine kinase activity modulate adenomatous polyposis coli protein-mediated regulation of b-catenin-lymphocyte enhancer-binding factor signaling

The ubiquitin-proteasome pathway and serine kinase activity modulate adenomatous polyposis coli protein-mediated regulation of beta-catenin-lymphocyte enhancer-binding factor signaling. Journal of Biological Chemistry 274(23): 16641-16645, 1999

Lymphoid enhancer factor-1 blocks adenomatous polyposis coli-mediated nuclear export and degradation of b-catenin. Regulation by histone deacetylase 1. The Journal of Biological Chemistry 277(27): 258-64, 2002

Lymphoid enhancer factor-1 blocks adenomatous polyposis coli-mediated nuclear export and degradation of beta-catenin. Regulation by histone deacetylase 1. Journal of Biological Chemistry 277(27): 24258-24264, 2002

Peroxisome Proliferator-activated Receptor g Activation Can Regulate b-Catenin Levels via a Proteasome-mediated and Adenomatous Polyposis Coli-independent Pathway. Journal of Biological Chemistry 279(34): 583-594, 2004

Peroxisome proliferator-activated receptor gamma activation can regulate beta-catenin levels via a proteasome-mediated and adenomatous polyposis coli-independent pathway. Journal of Biological Chemistry 279(34): 35583-35594, 2004

Adenomatous Polyposis Coli (APC)-independent Regulation of b-Catenin Degradation via a Retinoid X Receptor-mediated Pathway. The Journal of Biological Chemistry 278(32): 954-62, 2003

Adenomatous polyposis coli (APC)-independent regulation of beta-catenin degradation via a retinoid X receptor-mediated pathway. Journal of Biological Chemistry 278(32): 29954-29962, 2003

Transcriptional regulation of cyclooxygenase-2 in response to proteasome inhibitors involves reactive oxygen species-mediated signaling pathway and recruitment of CCAAT/enhancer-binding protein delta and CREB-binding protein. Molecular Biology of the Cell 16(12): 5579-5591, 2005

Adenomatous polyposis coli is down-regulated by the ubiquitin-proteasome pathway in a process facilitated by Axin. Journal of Biological Chemistry 279(47): 49188-49198, 2004

Adenomatous polyposis coli protein (Apc)-independent regulation of -catenin/Tcf-4 mediated transcription in intestinal cells. Biochemical Journal 344(2): 565-570, 1999

Activator Protein 2a Associates with Adenomatous Polyposis Coli/b-Catenin and Inhibits b-Catenin/T-cell Factor Transcriptional Activity in Colorectal Cancer Cells. Journal of Biological Chemistry 279(44): 669-675, 2004

Adenomatous polyposis coli protein (APC)-independent regulation of beta-catenin/Tcf-4 mediated transcription in intestinal cells. Biochemical Journal 344 Pt 2: 565-570, 1999

Differential formation of β-catenin/lymphoid enhancer factor-1 DNA binding complex induced by nitric oxide in mouse colonic epithelial cells differing in adenomatous polyposis coli (Apc) genotype. Cancer Research (Baltimore) 60(13): 3379-3383, 2000

Differential formation of beta-catenin/lymphoid enhancer factor-1 DNA binding complex induced by nitric oxide in mouse colonic epithelial cells differing in adenomatous polyposis coli (Apc) genotype. Cancer Research 60(13): 3379-3383, 2000

Adeno-Associated Virus 2-Mediated Gene Transfer: A Complex Interaction between Epidermal Growth Factor Receptor Protein Tyrosine Kinase Signaling and Ubiquitin/Proteasome Pathway in Transgene Expression. Molecular Therapy 13: S3-S4, 2006